ReviewMetabolites2021

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials.

Alessandro Mantovani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.